전남대학교 중앙도서관

링크메뉴

주메뉴

- 게시판
- 전시마당

- 게시판
- 전시마당

- 대출반납서비스
- 도서신청서비스
- 시설이용서비스
- 장애학생 지원서비스
- 타기관이용서비스
- 무인예약대출 서비스
- 학위논문파일 제출
- 개인정보관리
- 원문복사 신청/조회
- 상호대차 신청/조회
- 게시판
- 전시마당

도서관안내
시설안내
정보마루안내
4F
전자자료 상세검색

전자자료 상세검색

통합검색
소장자료
전자자료

통합검색

결과내 검색

검색어 [키워드: "Fenstad MH"]

총 26건

※ 중복 레코드가 제거된 검색 결과가 표시됩니다.

1/3 페이지

검색결과수정

검색범위확장
- Full Text내 키워드 확장
- 관련 주제어 확장
재검색
검색결과제한
- 원문(Full Text)
- Peer-Reviewed 학술지
- 발행년 -
재검색
자료유형
- Academic Journals (26)
주제
- pre-eclampsia (11)
- antiviral agents (3)
- covid-19 (3)
주제

Count Name
- pre-eclampsia (11)
- antiviral agents (3)
- covid-19 (3)
- decidua (3)
- pregnancy complications (3)
- arthritis, rheumatoid (2)
- betacoronavirus (2)
- cardiovascular diseases (2)
- coronavirus infections (2)
- gene expression profiling (2)
- lupus erythematosus, systemic (2)
- pneumonia, viral (2)
- sars-cov-2 (2)
- acyl-coa oxidase (1)
- b-cell activating factor (1)
- blood donors (1)
- carrier proteins (1)
- catechol o-methyltransferase (1)
- chromosomes, human, pair 13 (1)
- chromosomes, human, pair 2 (1)
- dermatitis, atopic (1)
- endometrium (1)
- endoplasmic reticulum stress (1)
- fetal growth retardation (1)
- gene expression regulation (1)
- gene regulatory networks (1)
- genetic predisposition to disease (1)
- genetic variation (1)
- genome-wide association study (1)
- haplotypes (1)
- hematologic tests (1)
- interferon-alpha (1)
- neutralization tests (1)
- registries (1)
- rheumatic diseases (1)
- sequence analysis (1)
- white people (1)
닫기
간행물
- molecular human reproduction (3)
- tidsskrift for den norske laegeforening tidsskrift for praktisk medicin ny raekke (3)
- viruses (3)
간행물

Count Name
- molecular human reproduction (3)
- tidsskrift for den norske laegeforening tidsskrift for praktisk medicin ny raekke (3)
- viruses (3)
- acta obstetricia et gynecologica scandinavica (1)
- american journal of obstetrics & gynecology (1)
- american journal of obstetrics and gynecology (1)
- annals of the rheumatic diseases (1)
- autoimmunity reviews (1)
- biorxiv the preprint server for biology (1)
- bmc pregnancy and childbirth (1)
- cancers (1)
- cell reports medicine (1)
- clinical and experimental rheumatology (1)
- european journal of human genetics ejhg (1)
- human genetics (1)
- international journal of infectious diseases ijid official publication of the international society for infectious diseases (1)
- oncotarget (1)
- placenta (1)
- plos one (1)
- pregnancy hypertension (1)
닫기
출판사
- elsevier (5)
- mdpi (4)
- norske laegeforening (3)
출판사

Count Name
- elsevier (5)
- mdpi (4)
- norske laegeforening (3)
- oxford university press for the european society for human reproduction and embryology (3)
- biomed central (1)
- bmj (1)
- cell press (1)
- clinical and experimental rheumatology s.a.s (1)
- elsevier b.v. (1)
- impact journals (1)
- nature publishing group (1)
- public library of science (1)
- springer verlag (1)
- wiley (1)
닫기
언어
- english (25)
- norwegian (3)
수록데이터베이스
- MEDLINE (25)
- CINAHL Plus with Full Text (1)

PQDT
CAJ
RISS
PsycINFO

전체선택

A transcriptional profile of the decidua in preeclampsia.

학술저널

issue: American Journal of Obstetrics & Gynecology (AM J OBSTET GYNECOL), Jan2011; 204(1): 84.e1-84.e27. (1p)
Author: Løset M; Mundal SB; Johnson MP; Fenstad MH; Freed KA; Lian IA; Eide IP; Bjørge L; Blangero J; Moses EK; Austgulen R; Løset, Mari; ¹Mundal, Siv B; Johnson, Matthew P; Fenstad, Mona H; Freed, Katherine A; Lian, Ingrid A; Eide, Irina P; Bjørge, Line; Blangero, John; et al
DB Label: Database : CINAHL Plus with Full Text

원문보기: Full Text (ScienceDirect) Full Text (Clinical Key) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR) 원문복사신청 - FRIC

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group.

학술저널

issue: Cancers [Cancers (Basel)] 2024 Feb 29; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 29.
Author: Partanen A; Department of Medicine, Kuopio University Hospital, 70210 Kuopio, Finland.
Waage A; Department of Hematology, St. Olavs Hospital, 7030 Trondheim, Norway.
Peceliunas V; Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital, 08661 Vilnius, Lithuania.
Schjesvold F; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, 0450 Oslo, Norway.; KG Jebsen Center for B Cell Malignancies, University of Oslo, 0316 Oslo, Norway.
Anttila P; Helsinki University Hospital Cancer Center Hematology, University of Helsinki, 00029 Helsinki, Finland.
Säily M; Hematology-Oncology Unit, Oulu University Hospital Hematology, 90220 Oulu, Finland.
Uttervall K; Medical Unit Hematology, Karolinska University Hospital, 171 64 Solna, Sweden.; Department of Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden.
Putkonen M; Department of Medicine, Turku University Hospital, 20521 Turku, Finland.
Carlson K; Department of Hematology, Uppsala University Hospital, 751 85 Uppsala, Sweden.
Haukas E; Stavanger University Hospital, 4011 Stavanger, Norway.
Sankelo M; Hematology Unit, Department of Internal Medicine, Tampere University Hospital Hematology, 33520 Tampere, Finland.
Szatkowski D; Department of Oncology, Hematology and Palliative Care, Foerde Central Hospital, 6812 Foerde, Norway.
Hansson M; Department of Hematology, Skåne University Hospital, 222 42 Lund, Sweden.
Marttila A; Department of Medicine, Kymenlaakso Central Hospital, 48210 Kotka, Finland.
Svensson R; Department of Hematology, Linköping University Hospital, 581 85 Linköping, Sweden.
Axelsson P; Department of Haematology, Helsingborg Hospital, 252 23 Helsingborg, Sweden.
Lauri B; Department of Hematology, Sunderby Hospital, 971 80 Luleå, Sweden.
Mikkola M; Department of Medicine, Päijät-Häme Central Hospital, 15850 Lahti, Finland.
Karlsson C; Department of Haematology, Halland Hospital, 302 33 Halmstad, Sweden.
Abelsson J; Department of Hematology, Uddevalla Hospital, 451 53 Uddevalla, Sweden.
Ahlstrand E; Department of Medicine, Örebro University Hospital, 701 85 Örebro, Sweden.
Sikiö A; Department of Medicine, Central Finland Central Hospital, 40620 Jyväskylä, Finland.
Klimkowska M; Department of Clinical Pathology and Cytology, Karolinska University Hospital, 141 86 Stockholm, Sweden.
Matuzeviciene R; Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Biomedical Sciences Institute, Vilnius University Hospital and Vilnius University Faculty of Medicine, 03101 Vilnius, Lithuania.
Fenstad MH; Department of Immunology and Transfusion Medicine, St. Olavs Hospital, 7030 Trondheim, Norway.
Ilveskero S; Clinical Chemistry, Helsinki University Hospital, University of Helsinki, 00014 Helsinki, Finland.
Pelliniemi TT; Fimlab Laboratories Ltd., 33520 Tampere, Finland.
Nahi H; Hematology Centre, Karolinska University Hospital Huddinge, 141 57 Stockholm, Sweden.
Silvennoinen R; Helsinki University Hospital Cancer Center Hematology, University of Helsinki, 00029 Helsinki, Finland.
DB Label: Database : MEDLINE

원문보기: Full Text (원문보기) Full Text (원문보기) Open Access (PubMed Central) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Single-cell resolution of longitudinal blood transcriptome profiles in rheumatoid arthritis, systemic lupus erythematosus and healthy control pregnancies.

학술저널

issue: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Feb 15; Vol. 83 (3), pp. 300-311. Date of Electronic Publication: 2024 Feb 15.
Author: Lien HJT; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway hilde.j.t.lien@ntnu.no.
Pedersen TT; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Norwegian National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway.
Jakobsen B; Norwegian National Advisory Unit on Pregnancy and Rheumatic Diseases, Department of Rheumatology, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway.
Flatberg A; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Genomics Core Facility, HF, Sentral Stab, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway.
Chawla K; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; BioCore - Bioinformatics Core Facility, HF, Sentral stab, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway.
Sætrom P; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Computer Science, Norwegian University of Science and Technology, Trondheim, Norway.
Fenstad MH; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olavs hospital, Trondheim University Hospital, Trondheim, Norway.
DB Label: Database : MEDLINE

원문보기: Full Text (BMJ Journals) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case study.

보고서

issue: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2023 Dec; Vol. 137, pp. 75-78. Date of Electronic Publication: 2023 Oct 17.
Author: Ravlo E; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
Ianevski A; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
Starheim E; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
Wang W; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
Ji P; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
Lysvand H; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway.
Smura T; Department of Virology, University of Helsinki, Helsinki, Finland; HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Kivi G; Icosagen Cell Factory OÜ, Tartu, Estonia.
Voolaid ML; Icosagen Cell Factory OÜ, Tartu, Estonia.
Plaan K; Icosagen Cell Factory OÜ, Tartu, Estonia.
Ustav M; Icosagen Cell Factory OÜ, Tartu, Estonia.
Ustav M Jr; Icosagen Cell Factory OÜ, Tartu, Estonia.
Zusinaite E; Institute of Technology, University of Tartu, Tartu, Estonia.
Tenson T; Institute of Technology, University of Tartu, Tartu, Estonia.
Kurg R; Institute of Technology, University of Tartu, Tartu, Estonia.
Oksenych V; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
Walstad K; Department of Immunology and Transfusion Medicine, St. Olavs Hospital, Trondheim, Norway.
Nordbø SA; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway; Department of Immunology and Transfusion Medicine, St. Olavs Hospital, Trondheim, Norway.
Kaarbø M; Department of Microbiology, Oslo University Hospital and University of Oslo, Oslo, Norway.
Ernits K; Department of Experimental Medicine, University of Lund, Lund, Sweden.
Bjørås M; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway; Department of Microbiology, Oslo University Hospital and University of Oslo, Oslo, Norway; Centre for Embryology and Healthy Development, University of Oslo and Oslo University Hospital, Oslo, Norway.
Kainov DE; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway; Institute of Technology, University of Tartu, Tartu, Estonia; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland. Electronic address: denis.kainov@ntnu.no.
Fenstad MH; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, Trondheim, Norway; Department of Immunology and Transfusion Medicine, St. Olavs Hospital, Trondheim, Norway.
DB Label: Database : MEDLINE

원문보기: Full Text (Clinical Key) Full Text (ScienceDirect O/A) 등재 - Web of Science (SCIE) 조회 - Impact Factor (JCR)

Low serum lipocalin-2 in pregnant women with systemic lupus erythematosus.

학술저널

issue: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2023 Sep; Vol. 41 (9), pp. 1838-1846. Date of Electronic Publication: 2023 May 24.
Author: Pedersen TT; Norwegian National Advisory Unit on Pregnancy and Rheumatic diseases, Department of Rheumatology, St. Olavs University Hospital, Trondheim, and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. tina.pedersen@stolav.no.
Fenstad MH; Department of Immunology and Transfusion Medicine, St. Olavs University Hospital, Trondheim, Norway.
Wallenius M; Norwegian National Advisory Unit on Pregnancy and Rheumatic diseases, Department of Rheumatology, St. Olavs University Hospital, Trondheim, and Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Hetlelid E; Department of Mathematical Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Follestad T; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Langaas M; Department of Mathematical Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Haug M; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim; Centre of Molecular Inflammation Research (CEMIR), NTNU, Trondheim; and Department of Infectious Diseases, St. Olavs University Hospital, Trondheim, Norway.
DB Label: Database : MEDLINE

원문보기: 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR) 원문복사신청 - FRIC

Convalescent plasma from Norwegian blood donors to treat COVID-19.
Rekonvalesensplasma mot covid-19 fremstilt fra norske blodgivere.

학술저널

issue: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2023 Jul 26; Vol. 143 (11). Date of Electronic Publication: 2023 Jul 26 (Print Publication: 2023).
Author: Nissen-Meyer LSH; Seksjon for blodgivning, Avdeling for immunologi og transfusjonsmedisin, Oslo universitetssykehus.
Steinsvåg TT; Avdeling for immunologi og transfusjonsmedisin, Sørlandet sykehus.
Fenstad MH; Avdeling for immunologi og transfusjonsmedisin, St. Olavs hospital.
Sørvoll IH; Nasjonal behandlingstjeneste for avansert trombocyttimmunologi, Laboratoriemedisin, Universitetssykehuset Nord-Norge.
Hvalryg M; Immunologisk og transfusjonsmedisinsk avdeling, Akershus universitetssykehus.
Titze TL; Avdeling for laboratoriemedisin, Seksjon blodbank, Drammen, Vestre Viken.
Magnussen K; Avdeling for blodbank og medisinsk biokjemi, Sykehuset Innlandet.
Kristoffersen G; Avdeling for immunologi og transfusjonsmedisin, Helse Stavanger.
Johnsen KMN; Senter for laboratoriemedisin, Blodbanken, Sykehuset Østfold.
Llohn AH; Immunologisk og transfusjonsmedisinsk avdeling, Akershus universitetssykehus.
Hermundstad B; Seksjon for komponentfremstilling, Immunologisk og transfusjonsmedisinsk avdeling, Akershus universitetssykehus.
Høiback LS; Seksjon blodbank, Sentrallaboratoriet, Sykehuset i Vestfold.
Haugen M; Avdeling for blodbank og medisinsk biokjemi, Sykehuset Innlandet.
Kristoffersen EK; Avdeling for immunologi og transfusjonsmedisin, Laboratorieklinikken, Haukeland universitetssjukehus, og, Klinisk institutt 2, Universitetet i Bergen.
Boulland LML; Seksjon for transplantasjonsimmunologi, Avdeling for immunologi og transfusjonsmedisin, Oslo universitetssykehus.
Kran AB; Folkehelseinstituttet, og, Mikrobiologisk avdeling, Oslo universitetssykehus.
Lund-Johansen F; Avdeling for immunologi og transfusjonsmedisin, Oslo universitetssykehus.
Vaage JT; Avdeling for immunologi og transfusjonsmedisin, Oslo universitetssykehus.
Flesland Ø; Avdeling for kvalitetsforbedring og pasientsikkerhet, Helsedirektoratet.
Hervig TA; Irish Blood Transfusion Service, Dublin, og, Trinity College, Dublin.
DB Label: Database : MEDLINE

원문보기: 등재 - SCOPUS 조회 - Impact Factor (JCR)

COVID-19 patients treated with convalescent plasma.
Covid-19-pasienter behandlet med rekonvalesensplasma.

학술저널

issue: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2023 Jul 26; Vol. 143 (11). Date of Electronic Publication: 2023 Jul 26 (Print Publication: 2023).
Author: Nissen-Meyer LSH; Seksjon for blodgivning, Avdeling for immunologi og transfusjonsmedisin, Oslo universitetssykehus.
Macpherson ME; Infeksjonsmedisinsk avdeling, Oslo universitetssykehus.
Skeie LG; Infeksjonsmedisinsk avdeling, Oslo universitetssykehus.
Hvalryg M; Immunologisk og transfusjonsmedisinsk avdeling, Akershus universitetssykehus.
Llohn AH; Immunologisk og transfusjonsmedisinsk avdeling, Akershus universitetssykehus.
Steinsvåg TT; Avdeling for immunologi og transfusjonsmedisin, Sørlandet sykehus.
Fenstad MH; Avdeling for immunologi og transfusjonsmedisin, St. Olavs hospital.
Tveita A; Medisinsk avdeling, Bærum sykehus, og, K.G. Jebsen-senter for B-cellekreft, Oslo universitetssykehus.
Kristoffersen EK; Avdeling for immunologi og transfusjonsmedisin, Laboratorieklinikken, Haukeland universitetssjukehus, og, Klinisk institutt 2, Universitetet i Bergen.
Sundic T; Avdeling for laboratoriemedisin, Helse Fonna.
Lund-Johansen F; Avdeling for immunologi og transfusjonsmedisin, Oslo universitetssykehus.
Vaage JT; Avdeling for immunologi og transfusjonsmedisin, Oslo universitetssykehus.
Flesland Ø; Avdeling kvalitetsforbedring og pasientsikkerhet, Helsedirektoratet.
Dyrhol-Riise AM; Infeksjonsmedisinsk avdeling, Oslo universitetssykehus, og, Institutt for klinisk medisin, Universitetet i Oslo.
Holter JC; Avdeling for mikrobiologi, Oslo universitetssykehus.
Hervig TA; Irish Blood Transfusion Service, Dublin, og, Trinity College, Dublin.
Fevang B; Seksjon for klinisk immunologi og infeksjonssykdommer, Oslo universitetssykehus, Rikshospitalet.
DB Label: Database : MEDLINE

원문보기: 등재 - SCOPUS 조회 - Impact Factor (JCR)

[How often should blood tests be repeated?].
Hvor ofte bør man gjenta blodprøver?

학술저널

issue: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2023 Jan 12; Vol. 143 (1). Date of Electronic Publication: 2023 Jan 12 (Print Publication: 2023).
Author: Nome RV
Amundsen EK
Tvedt THA
Fenstad MH
Øie E
DB Label: Database : MEDLINE